Live feed07:00:00·132dPRReleasevia QuantisnowPositive and clinically meaningful results from the Phase III KALOS and LOGOS trials for BREZTRI in patients with uncontrolled asthma published in The Lancet Respiratory MedicineByQuantisnow·Wall Street's wire, on your screen.AZN· AstraZeneca PLCHealth Care
